PHM — Pharma Mar SA Cashflow Statement
0.000.00%
Last trade - 00:00- €1.28bn
- €1.19bn
- €174.86m
Annual cashflow statement for Pharma Mar SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 146 | 95.1 | 43.8 | -3.62 | 12 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 10.6 | -2.76 | 15.6 | 1.07 | -7.44 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 116 | -72.3 | -27 | -16.6 | -5.29 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 279 | 25.7 | 38.3 | -13.4 | 6.03 |
| Capital Expenditures | -3 | -7.8 | -8.85 | -16 | -15.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -116 | 26.3 | 19.7 | -27.1 | 16.5 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -119 | 18.5 | 10.9 | -43 | 1.03 |
| Financing Cash Flow Items | — | 0 | — | — | -0.938 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -73.8 | -27.4 | -13.4 | -32.1 | -5.35 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 78.6 | 17.1 | 36.5 | -89.8 | 3.21 |